Study of Bexarotene in Patients With Acute Myeloid Leukemia

NCT00316030 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

AML
Acute Myeloid Leukemia

Interventions

DRUG: Bexarotene

Sponsor

Abramson Cancer Center at Penn Medicine